U.K. Court Affirms Ruling Revoking Stent Patent

Law360, New York (January 16, 2007, 12:00 AM EST) -- In the latest development in a series of legal battles over the lucrative market for drug-eluting coronary stents, a U.K. court Tuesday dismissed an appeal of a lower court’s decision to revoke a patent owned by Angiotech Pharmaceuticals Inc. and licensed by Boston Scientific Corp.

The U.K. Court of Appeals’ decision affirmed a February 24, 2006 ruling by the Patents Court in the Chancery Division of the High Court of Justice, which granted plaintiff Conor Medsystems Inc. a win by finding that the U.K. portion of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.